American Conference Institute (ACI) will be offering a webinar entitled: "Pharmaceutical Antitrust Initiatives and Developments in the U.S. and Abroad" on July 29, 2009 from 1:00-2:30 PM (EST). Seth Silber of Wilson Sonsini Goodrich & Rosati and Jeffrey Brennan of Dechert LLP, both of whom were senior-level attorneys with the Federal Trade Commission, will provide insights into what the U.S. pharmaceutical industry can expect to see in terms of antitrust enforcement, particularly in light of the recent release of the European Commission (EC) Pharmaceutical Sector Inquiry Report. In particular, the speakers will address the following topics:
• An overview of the findings of the following recently released reports and what affect the various findings in these reports may have on pharmaceutical antitrust enforcement and activity both in the U.S and abroad:
• EC Pharmaceutical Sector Inquiry Report
• Authorized Generic Drug Study
• Follow-On Biologic Drug Competition Report
• Update on current legislative initiatives affecting the pharmaceutical industry, including the Consumer Access to Generic Drugs Act of 2009
• Reverse settlement payments, switch strategies, and the current thinking on the aggregation of U.S. IP rights
There is no registration fee for this webinar. Those interested in registering for the webinar, can do so here, or by calling 888-224-2480.
Patent Docs is a media partner of this webinar.
Comments